Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jan 29,2021
Consistency Evaluation of Generic Drugs, Bulk Drug Particle Size Control Needs Attention
In the development of formulation, due to the different synthesis processes of raw materials from different sources, there may be differences in their solubility, crystal form, particle size, and impurities, which may affect the consistency of the product. In the evaluation of the consistency of generic drugs, the particle size control of raw materials shouldRead more
More
Consistency Evaluation of Generic Drugs, Bulk Drug Particle Size Control Needs Attention
Jan 28,2021
Three Ways to Improve the Bioavailability of Poorly Soluble Drugs
Due to the difference in particle size or added excipients of poorly soluble drugs, the oral dose will be the same, but the efficacy will be very different. In the development of solid preparations, increasing the solubility of poorly soluble drugs and improving the bioavailability of drugs, thereby promoting the absorption of drugs in theRead more
More
Three Ways to Improve the Bioavailability of Poorly Soluble Drugs
Jan 28,2021
Nature: There is no Paralyzed Patient, and the Days of Freedom are not Far Away
The team created a “designer” signaling protein and injected it into the brains of animals to stimulate their nerves. The cells regenerate and share the recipe for making the protein. The research was published in Nature recently. Nature: There is no paralyzed patient, and the days of freedom are not far away Spinal cord injuryRead more
More
Jan 28,2021
COVID-19: The Virus Keeps Mutating, is Our Vaccine Still Effective?
Recent viral mutations of COVID-19 may inhibit the effectiveness of the current two vaccines to a certain extent. Researchers have recently expressed concern about this preliminary finding, because it also largely predicts that future mutations may destroy the vaccine's effectiveness. Effectiveness. The study tested coronaviruses from the United Kingdom, South Africa, and Brazil, and wasRead more
More
COVID-19: The Virus Keeps Mutating, is Our Vaccine Still Effective?
Jan 27,2021
Analysis on the Benefits of Innovative Drug Release Technology in Drug Development
Compared with the research and development of new entity drugs, the research and development of innovative drug preparations has the advantages of low cost, short cycle and quick effect. Preparation technology innovation, drug delivery route innovation, drug dosage form innovation, drug delivery plan innovation, and packaging innovation are all important technologies for the development ofRead more
More
Jan 27,2021
Factors Affecting the Stability of Antibody Drugs: Glycosylation Modification
As an important biotechnology drug, the emergence of monoclonal antibody drugs provides a brand new approach for the treatment of various diseases such as cancer, autoimmune diseases and viral infections. Glycosylation modification is an important factor affecting the biological characteristics of monoclonal antibody drug structure, function development and pharmacokinetics. The most obvious effect of proteinRead more
More
Factors Affecting the Stability of Antibody Drugs: Glycosylation Modification
Jan 27,2021
Analysis on the Preparation and Development Trend of Monoclonal Antibodies
Currently, monoclonal antibody cloning drugs, protein drugs, gene and nucleic acid drugs, etc. are the focus of my country's biopharmaceutical research and development. Among them, monoclonal antibody drugs, as a biologically targeted drug with unique advantages, have high specificity, strong targeting and the characteristic of low toxicity and side effects is remarkable in treating diseases.Read more
More
Analysis on the Preparation and Development Trend of Monoclonal Antibodies
Jan 27,2021
Analysis on the Composition and Preparation Process of Oral Solid Preparations
Oral solid preparations are the preferred dosage form in clinical use, including oral powders, granules, tablets, capsules and dripping pills. They have good physical and chemical stability, low production and manufacturing costs, and are more convenient to take and carry. Features. In the research and development of solid preparations, the formulation of dosage formsRead more
More
Analysis on the Composition and Preparation Process of Oral Solid Preparations
Jan 26,2021
Analysis on the Role of Dissolution Test in Evaluating the Quality of Medicine
The consistency evaluation of the quality and efficacy of the generic drug requires that the generic drug and the reference preparation have the same quality attributes and clinical efficacy. In the consistency evaluation of the generic drug, effective methods are adopted to accurately evaluate the drug’s in vivo and in vitro correlation (IVIVC) Is anRead more
More
Jan 26,2021
How Much do You Know about the BE Test?
Bioequivalence test, also known as BE test, refers to the use of bioavailability research methods, using pharmacokinetic parameters as indicators to compare the same or different formulations of the same drug under the same test conditions. The human body test whether there is statistical difference in the absorption degree and speed of the active ingredient.
More
How Much do You Know about the BE Test?
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->